Form 4 for CYRX Cryoport, Inc.
Accepted 2025-08-04 00:00:00 ET · period of report 2025-07-31 · accession 0001104659-25-073737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-04 | 2025-07-31 | CYRX | SHELTON JERRELL | Pres, CEO, Dir | M - OptEx | $5.00 | +25.0K | 1.04M | +2% | +$125.0K |
| D | 2025-08-04 | 2025-07-31 | CYRX | SHELTON JERRELL | Pres, CEO, Dir | M - OptEx | $0.00 | -25.0K | 25.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-31 | M | A | 25,000 | $5.00 | 1,037,419 | D | — | — | (F1) This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. |
| 2 | Derivative | Stock Option (right to buy) | 2025-07-31 | M | D | 25,000 | $0.00 | 25,000 | D | $5.00 · — to 2025-08-20 | 25,000 Common Stock | (F1) This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. (F2) 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015. |